NASDAQ: PLSM
Pulsenmore Ltd Earnings Dates, Reports, Calls

Pulsenmore earnings were -$5.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest PLSM earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PLSM reported annual earnings of -$5.0M, with -50.5% growth.

PLSM earnings history

Current Revenue
$12.5M
Current Earnings
-$5.0M
Current Profit Margin
-39.6%

PLSM Return on Equity

Current Company
-17.6%
Current Industry
8.8%
Current Market
28.9%
PLSM's Return on Equity (-17.6%)... subscribe to Premium to read more.
High Return on Equity Performance

PLSM Return on Assets

Current Company
-13%
Current Industry
5.4%
PLSM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PLSM announces earnings.

PLSM Return on Capital Employed

Current Company
-21.35%
Current Industry
9.4%

PLSM vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PLSM-$5.36M-$5.08MN/A-$0.79
ADGM-$21.21M-$25.08MN/A-$1.51
ICCM-$14.80M-$15.06MN/A-$0.24
MOVE-$15.17M-$18.32MN/A-$21.79
IRIX-$2.83M-$4.44MN/A-$0.26

Pulsenmore Earnings Reports & History FAQ

What were Pulsenmore's earnings last quarter?

Pulsenmore (NASDAQ: PLSM) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total PLSM earnings for the quarter were N/A. In the same quarter last year, Pulsenmore's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Pulsenmore stock.

Is Pulsenmore profitable or losing money?

As of the last Pulsenmore earnings report, Pulsenmore is currently losing money. Pulsenmore's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$4.97 million, a 50.49% decrease year over year.

What was PLSM's earnings growth in the past year?

As of Pulsenmore's earnings date in Q2 2026, Pulsenmore's earnings has grown year over year. PLSM earnings in the past year totalled -$5.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.